Ultragenyx Pharmaceutical
RARE
#3251
Rank
โ‚ฌ3.23 B
Marketcap
33,50ย โ‚ฌ
Share price
-4.26%
Change (1 day)
-23.03%
Change (1 year)

Ultragenyx Pharmaceutical (RARE) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : โ‚ฌ1.14 Billion

According to Ultragenyx Pharmaceutical's latest financial reports the company's total liabilities are โ‚ฌ1.14 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Ultragenyx Pharmaceutical - Total liabilities on balance sheet (from 2012 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚ฌ1.19 B8.47%
2023-12-31โ‚ฌ1.09 B-1.12%
2022-12-31โ‚ฌ1.11 B109.97%
2021-12-31โ‚ฌ0.52 B7.65%
2020-12-31โ‚ฌ0.49 B14.42%
2019-12-31โ‚ฌ0.43 B344.6%
2018-12-31โ‚ฌ96.72 M8.16%
2017-12-31โ‚ฌ89.42 M41.13%
2016-12-31โ‚ฌ63.36 M143.28%
2015-12-31โ‚ฌ26.04 M143.26%
2014-12-31โ‚ฌ10.7 M55%
2013-12-31โ‚ฌ6.9 M129.82%
2012-12-31โ‚ฌ3 M162.69%
2011-12-31โ‚ฌ1.14 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚ฌ1.23 B 7.23%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.54 B-52.38%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.67 B-40.98%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.14 B-87.72%๐Ÿ‡บ๐Ÿ‡ธ USA